BioSpace News Archive

Innovative medical device manufacturer Anatomics Pty Ltd announces the world first use of revolutionary StarPore polymer tissue scaffold for thoracic reconstructive surgery in Australia, USA, UK, Singapore, Portugal and New Zealand.

Biogen Inc. announced that Alfred “Al” W. Sandrock, Jr., M.D., Ph.D., Head of Research & Development, will retire from the Company effective December 31, 2021.

Athos Therapeutics, Inc. announced today the completion of an oversubscribed $15MM Series A financing.

The Company’s common stock will begin trading under the symbol “ANVS” at the opening of trading on November 18, 2021.

Siemens Healthineers is proud to be recognized in Stage I of the Foundation for the National Institutes of Health Biomarkers Consortium Non-Invasive Biomarkers of Metabolic Liver Disease study.

Bristol Myers Squibb (NYSE:BMY) in collaboration with Janssen Pharmaceuticals, Inc. today announced results from the Phase 2 AXIOMATIC-TKR study

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present its Chikungunya vaccine candidate, VLA1553, on November 18 and 19, 2021 during the American Society of Tropical Medicine & Hygiene (ASTMH) 2021 Annual Meeting.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) collaborator Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, presented clinical data from REEF-1, a Phase 2b study of different combination regimens, including JNJ-73763989 (JNJ-3989), formerly called ARO-HBV, and/or JNJ-56136379 (JNJ-6379), and a nucleos(t)ide analog (NA) for the treatment of chronic hepatitis B virus infection (CHB).

Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, reported financial results for the third quarter ended September 30, 2021.

HeartFlow, Inc., the leader in revolutionizing precision heart care, announced the appointment of Wayne J. Riley, MD, to its Board of Directors.